Latest statistics on coronavirus cases and deaths in Indiana released
The total number of COVID-19 cases on Saturday was 3,953. Of these, 53.8% are women.
Here is a complete breakdown of the age groups making up the positive cases:
- 0-19: 1.6 percent
- 20-29: 10.4 percent
- 30-39: 13.7 percent
- 40-49: 17 percent
- 50-59: 19.9 percent
- 60-69: 17.4 percent
- 70-79: 12 percent
- 80+: 8 percent
The health department reported 116 deaths. Of these deaths, 59.8% were men.
Here is a full breakdown of the age groups making up deaths from COVID-19:
- 0-19: 0 percent
- 20-29: 0 percent
- 30-39: 1.7 percent
- 40-49: 1.7 percent
- 50-59: 8.6 percent
- 60-69: 17.2 percent
- 70-79: 31.9 percent
- 80+: 38.8 percent
GDI confirms 14 more deaths – the total number of deaths from influenza in the state for the season
The Indiana State Department of Health reports 516 new positive COVID-19 cases in the state – an increase of 15% from the previous day’s figures.
On Saturday morning, 3,953 people tested positive for the coronavirus.
The GDI reports that 14 other people have died, bringing the state’s total death toll to 116, which is equivalent to the total number of people who died from the flu this season.
The 14 deaths have been reported in the following counties:
- Clark – 1 (total to 3)
- Hendricks – 3 (total to 4)
- Johnson – 2 (total to 6)
- Lake – 1 (total to 8)
- LaPorte – 1 (total to 2)
- Lawrence – 1 (total to 5)
- Madison – 2 (total to 9)
- Marion – 1 (total to 34)
- Ripley – 1 (total to 2)
- Vigo – 1 (total to 2)
On Friday, Martin and Union counties recorded their first cases of positive coronaviruses. Only five of the 93 counties in the state remain without a single positive case (Benton, Daviess, Perry, Pike and Pulaski).
As of Friday, 1,965 people were tested for coronavirus, bringing the total to 19,800 people.
Worldwide cases reach 1.1 million, death toll in the United States exceeds 7,100
The number of US deaths from COVID-19 was more than 7,100 at 4:45 a.m. EST on Saturday, according to figures from Johns Hopkins University. More than a quarter of them are in New York.
The global total of confirmed cases of COVID-19 is just over 1.1 million, with nearly 59,000 deaths and 226,000 recoveries.
For most people, the coronavirus causes mild or moderate symptoms, such as fever and cough, which go away within two to three weeks. For some, especially the elderly and people with existing health conditions, this can cause more serious illnesses, including pneumonia and death.
Britain could ease lockdown by end of May
A scientist advising the UK government on the coronavirus pandemic says it may be possible to loosen some lockdown measures by the end of May.
The UK has been locked since March 23, with schools, bars, many shops and gathering places closed and people only having to go out for basic necessities or exercise.
Imperial College London epidemiologist Neil Ferguson, who sits on the government’s science advisory board, said, “We want to move to a situation where, at least by the end of May, we can replace some less intensive measures, more based on technology and testing, for the full lockdown that we have now. “
He told the BBC that if the number of cases started to drop soon, “we can switch to a diet that will not be a normal life, let me emphasize, but that will be a little more relaxed in terms of distancing social and economic, but relying more on testing. ”
Newborn twins named Corona and Covid
A couple from the Indian state of Chhattisgarh have named their newborn twins Corona and Covid.
The twins – a boy and a girl – were born during the 21-day national closure that started on March 24.
“The delivery took place after encountering several difficulties and, therefore, my husband and I wanted to make the day memorable,” Preeti Verma, the mother of the 27-year-old twins, told the Press Trust of news agency. India.
The couple said the names would remind them of the difficulties they encountered during the lockdown and before the successful delivery to a public hospital last week.
FDA fully approves KN95 masks for emergency use
The FDA has published a FAQ indicating whether respirators approved to standards used in other countries, such as KN95, can be used in the United States during the COVID-19 pandemic.
The short answer is yes.
In response to the continuing shortage of respirators, the FDA has also issued a new emergency use authorization (EUA) for respirators not approved by NIOSH made in China, making KN95 respirators eligible for authorization if certain criteria are met, including evidence that the respirator is authentic.
Finally, the FDA has revised an effective directive immediately to help expand the availability of general purpose masks for the general public and respirators (including N95 and KN95) for healthcare professionals during this pandemic.